13.3 Packaging and the Poison Prevention Packaging Act

Why the cap is a scored federal rule

Quick Answer: The Poison Prevention Packaging Act (PPPA) requires child-resistant (special) packaging for oral prescription drugs (16 CFR 1700.14(a)(10)) and oral controlled substances ((a)(4)). 15 U.S.C. § 1473(b) allows a noncomplying (easy-open) package only when the prescriber directs it or the purchaser requests it. Sublingual nitroglycerin is exempt (16 CFR 1700.14(a)(10)(i)). Document the easy-open request. Institutional unit-dose for on-site administration is not household packaging; a vial going home is.

NABP Competency 3.6 is packaging. Chapter 6.3 introduced PPPA next to DSCSA and HIPAA. This section is the Saturday decision: CRC vial, snap-cap, manufacturer mnemonic pack, or unit-dose cassette. Connecticut has not enacted a stricter statewide CRC statute that replaces the federal Act. More-restrictive still wins if a future Connecticut rule appears; today the CPSC text is the exam’s packaging law.

The PPPA (15 U.S.C. §§ 1471–1477) is a CPSC statute, not an FDA labeling statute and not a Commission of Pharmacy regulation. Special packaging means a package designed to be significantly difficult for children under five to open or to obtain a toxic amount within a reasonable time, and not difficult for normal adults to use properly (15 U.S.C. § 1471; test protocol 16 CFR 1700.20). Adult-friendly CRC exists; “the patient is 82” is not, by itself, a waiver.

Default — CRC for oral Rx drugs

16 CFR 1700.14(a)(10) requires special packaging for any drug for human use that is in a dosage form intended for oral administration and that federal law requires to be dispensed only on prescription, except the listed exemptions. 16 CFR 1700.14(a)(4) separately requires special packaging for oral controlled substances. Inhalers, topicals, injectables, and ear/eye drops are not in the oral-Rx sentence. A community pharmacist who puts every oral tablet in a snap-cap because “seniors prefer them” is running an illegal default, not a PPPA exception.

The dispensing pharmacist is responsible for the package that leaves the pharmacy. Manufacturer CRC stock bottles used as the dispensed container can satisfy the Act if they still meet the protocol after the pharmacist has opened and resealed them. A bulk stock bottle poured into a non-CRC vial, without a request or exemption, is the violation.

Who may waive CRC — patient or prescriber, not the pharmacist’s convenience

15 U.S.C. § 1473(b) (PPPA section 4(b)) is the waiver. For a household substance subject to a special-packaging standard and dispensed pursuant to an order of a physician, dentist, or other licensed practitioner authorized to prescribe, the substance may be dispensed in noncomplying packages only when directed in such order or when requested by the purchaser.

Consequences for the MPJE:

• The patient (purchaser) may request easy-open for one prescription or, if the request is clear, for all of that patient’s oral medications. CPSC has long treated a specific all-prescriptions request as lawful. A silent profile is not a blanket waiver.
• The prescriber may direct non-CRC on that order (“no safety cap”). That direction is drug-specific unless the order is written more broadly. It does not authorize the pharmacy to convert every other drug in the profile.
• The pharmacist may not decide, unilaterally, that arthritis or age makes CRC optional. Offer CRC; honor a request.
• A caregiver picking up is not automatically the “purchaser.” Get the patient’s request on file when someone else is at the window, or follow a prescriber’s written direction.

Document the request. The PPPA does not prescribe a Connecticut-specific form, and Chapter 400j has not published a unique easy-open affidavit. An undocumented “she always wants snap-caps” is how a later toddler ingestion becomes an unprovable file. Note who requested (patient or prescriber), when, and whether it is this Rx only or a standing patient-level request. Revisit a standing waiver when the household changes (grandchildren in the home).

16 CFR 1700.5’s “This Package for Households Without Young Children” statement is the manufacturer one-size noncomplying OTC rule. It is not a license to label every pharmacy vial that way and skip CRC. Chapter 6.3 already used that trap; do not reuse it as the outpatient default.

Listed exemptions — SL nitroglycerin is the prototype

16 CFR 1700.14(a)(10) then lists products that need not be in special packaging. High-yield for this exam:

• Sublingual dosage forms of nitroglycerin — (a)(10)(i). The classic easy-open manufacturer bottle. Do not pour SL NTG into a CRC vial “to be extra safe” if that delays self-administration in angina; the exemption exists because time to open is a clinical risk.
• Sublingual and chewable isosorbide dinitrate in strengths of 10 mg or less — (a)(10)(ii).
• Mnemonic oral-contraceptive packs that rely solely on progestogen or estrogen — (a)(10)(iv); hormone-replacement products on the same theory — (a)(10)(xxi).
• Selected unit-dose potassium supplements (≤ 50 mEq/unit), certain pancrelipase preparations, and other listed packages (erythromycin ethylsuccinate quantity limits, sodium fluoride package limits, and others in (iii)–(xxiv)).

An exemption is product-specific. Exempt SL nitroglycerin does not exempt the same patient’s oral isosorbide tablets that are not SL/chewable 10 mg or less. Exempt oral contraceptives in the manufacturer mnemonic pack do not exempt a bulk vial of the same hormone if the pharmacy repacks it into a 30-count bottle — unless the patient or prescriber requests easy-open or another exemption applies.

Institutional unit-dose versus household use

The PPPA regulates household substances — substances customarily used or stored in or about the household (15 U.S.C. § 1471). Drugs administered by staff inside a hospital, nursing facility, or similar institution are not being packaged for household use. Unit-dose (and unit-of-use) systems used for institutional administration are therefore not required to wear community CRC vials. That matches how 21 CFR 1306.14(c) / 1306.24(c) treat institutional CS labeling when the drug is never in the ultimate user’s possession before administration.

The trap is discharge and leave of absence. A seven-day unit-dose card handed to the patient to take home is household packaging. Apply CRC, a listed exemption, or a documented easy-open request. Do not cite “we’re a hospital pharmacy” as a blanket PPPA waiver for every bag that walks out the lobby.

Connecticut community technician ratios already treat unit-dose / unit-of-use as a distinct workflow (RCSA § 20-576-36; Chapter 4). That ratio rule is not a packaging exemption. Packaging still follows CPSC when the product is for household use.

Realistic Connecticut scenarios

A 78-year-old in Norwalk asks for snap-caps on her lisinopril only. Document patient request, this prescription. Keep her warfarin in CRC unless she (or the prescriber) also waives that drug. Refusing all snap-caps because “Connecticut never allows them” is false. Defaulting her entire profile to snap-caps because she is elderly, with no request, is also false.

A New Haven cardiology prescription for SL nitroglycerin 0.4 mg arrives. Dispense the manufacturer’s non-CRC bottle. Counseling still covers storage, expiration after opening if the manufacturer so states, and when to call 911 — auxiliary labels and CRC theory do not replace that discussion (Chapter 11).

A Hartford hospital pharmacy sends a 24-hour unit-dose drawer of oral medications to an inpatient unit. PPPA household CRC is not the test. The same pharmacist filling a discharge bottle of oral oxycodone for the household must use CRC unless the patient or prescriber has requested otherwise. 16 CFR 1700.14(a)(4) does not care that the patient was an inpatient this morning.

Official anchors

• 15 U.S.C. § 1473(b) — prescriber direction or purchaser request for noncomplying packaging.
• 16 CFR 1700.14 — oral Rx drugs and oral CS requiring special packaging; SL nitroglycerin and other exemptions.
• 16 CFR 1700.15 / 1700.20 — special-packaging standards and child-test protocol.